Piñero, F., Thompson, M., Marín, J. I., & Silva, M. (2020). Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients? World J Transplant.
शिकागो स्टाइल उद्धरणPiñero, Federico, Marcos Thompson, Juan Ignacio Marín, और Marcelo Silva. "Lenvatinib As First-line Therapy for Recurrent hepatocellular Carcinoma After Liver Transplantation: Is the Current Evidence Applicable to These Patients?" World J Transplant 2020.
एमएलए उद्धरणPiñero, Federico, Marcos Thompson, Juan Ignacio Marín, और Marcelo Silva. "Lenvatinib As First-line Therapy for Recurrent hepatocellular Carcinoma After Liver Transplantation: Is the Current Evidence Applicable to These Patients?" World J Transplant 2020.